Your browser doesn't support javascript.
loading
Efficacy of Sub-Tenon Micro-Perfusion of Cyclophosphamide in Rabbits with Severe Ocular Inflammation.
Zhao, Libei; Peng, Manqiang; Lin, Wenxiang; Tan, Qian; Khan, Muhammad Ahmad; Lin, Ding.
Afiliação
  • Zhao L; Department of Ophthalmology, Changsha Aier Eye Hospital, Aier School of Ophthalmology, Central South University, Changsha, People's Republic of China.
  • Peng M; Department of Ophthalmology, Changsha Aier Eye Hospital, Aier School of Ophthalmology, Central South University, Changsha, People's Republic of China.
  • Lin W; Department of Ophthalmology, Changsha Aier Eye Hospital, Aier School of Ophthalmology, Central South University, Changsha, People's Republic of China.
  • Tan Q; Department of Ophthalmology, Changsha Aier Eye Hospital, Aier School of Ophthalmology, Central South University, Changsha, People's Republic of China.
  • Khan MA; Department of Ophthalmology, Changsha Aier Eye Hospital, Aier School of Ophthalmology, Central South University, Changsha, People's Republic of China.
  • Lin D; Department of Ophthalmology, Changsha Aier Eye Hospital, Aier School of Ophthalmology, Central South University, Changsha, People's Republic of China.
Drug Des Devel Ther ; 14: 3407-3416, 2020.
Article em En | MEDLINE | ID: mdl-32903954

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Soluções Oftálmicas / Uveíte / Ciclofosfamida / Inflamação / Anti-Inflamatórios Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Drug Des Devel Ther Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Soluções Oftálmicas / Uveíte / Ciclofosfamida / Inflamação / Anti-Inflamatórios Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Drug Des Devel Ther Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2020 Tipo de documento: Article